3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
19
Neoplasm Metastasis
6
Brain Neoplasms
4
Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Triple Negative Breast Neoplasms
2
Lung Neoplasms
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Salivary Gland Neoplasms
1
Rare Tumour
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Neuroma, Acoustic
1
Neurofibromatosis 2
1
Meningioma
1
Malignant Female Reproductive System Neoplasm
1
Hemangiosarcoma
1
HER2-positive Breast Cancer
1
HER2 Positive Breast Carcinoma
1
Glioblastoma
1
Fallopian Tube Neoplasms
1
Ependymoma
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Pancreatic Ductal
1
Carcinoma, Lobular
1
Carcinoma
1
Interventions
trastuzumab deruxtecan
2
neratinib
1
Radiosurgery
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Breast Cancer With Brain Metastasis
×
neratinib
×
Clear all
NCT07152782
2025-09-03
THUNDER
Fudan University
Phase 2
Not yet recruiting
202 enrolled